RecruitingNCT07800247
Hemoglobin Disorders in Egypt: Sickle Cell Disease Ain Shams University Institutional Registry
Sponsor
Ain Shams University
Enrollment
400 participants
Start Date
Mar 17, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This is a retrospective descriptive study to create an institutional registry that will continue as a prospective follow-up non-intervention study that will be carried out at Hematology Oncology and BMT Department, Children's Hospital, Ain-Shams University, Cairo, Egypt.
Eligibility
Max Age: 39 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with sickle cell disease (scd). The study is currently recruiting participants at 2 locations. People eligible for this study include up to age 39 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07800247
Related Trials
Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia
NCT06761560
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
NCT0694138937 locations
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
NCT066659972 locations
Sickle Cell Kidney Biorepository
NCT070641742 locations
Exploratory Study on Global Reflexology in Sickle Cell Disease
NCT066191971 location